Alterity Therapeutics Inc. (ATHE) stock fell during pre-market. What’s behind this downfall?
Alterity Therapeutics Inc. (NASDAQ: ATHE) stock gained by 7.91% at last close whereas the ATHE stock price declines by 3.33% in the pre-market trading session. Alterity Therapeutics is a clinical-stage biotech firm devoted to a better future for those suffering from neurodegenerative disorders. ATH434 which is ATHE’s main asset, has the potential to treat a […]
Alterity Therapeutics Ltd. (ATHE) Stock Prices on the Rise Following Promising Progress of ATH434 Development
Alterity Therapeutics Ltd. (ATHE) stock prices were up by 8.77% as of the market closing on May 14th, 2021, bringing the price per share up to USD$1.24. Solid Liquidity Position In an update on company activities for the quarter ending 31st March 2021, ATHE announced a solid liquidity position of USD$32.8 million. Along with operational […]
